DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 93 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactResults

Sun Pharmaceutical Industries Limited — Board Meeting Intimation

NSE 2 hrs ago·14 Oct 2026, 2:53 pm

SUN Pharmaceutical IND L

Sun Pharmaceutical Industries has announced a board meeting scheduled for October 30, 2026. The primary agenda for this session is to review and approve the company's unaudited financial results for the quarter that ended in September 2026.

This announcement is a routine corporate disclosure that signals the upcoming release of quarterly performance data. For investors, this meeting date is a key milestone, as it marks the period when the market will receive fresh insights into the company's operational health and financial trajectory.

Investors should monitor the release of these results closely to assess the company's growth momentum and profitability trends in the third quarter of the fiscal year.